Selective liver targeting of antivirals by recombinant chylomicrons — a new therapeutic approach to hepatitis B (original) (raw)

References

  1. Tiollais, P., Pourcel, C. & Dejean, A. The hepatitis B virus. Nature (London) 317, 489–495 (1985).
    Article CAS Google Scholar
  2. Yoffe, B. & Noonan, C.A. Hepatitis B virus: new and evolving issues. Digest. Dis. Sci. 37, 1–9 (1992).
    Article CAS Google Scholar
  3. Beasley, R.P., Hwang, L.Y., Lin, C.C. & Chien, C.S. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. Lancet 2, 1129–1133 (1981).
    Article CAS Google Scholar
  4. Beasley, R.P. The major etiology of hepatocellular carcinoma. Cancer 61, 1942–1956 (1988).
    Article CAS Google Scholar
  5. Ueda, K., Tsurimoto, T., Nagahata, T., Chisaka, O. & Matsubara, K., An in vitro system for screening anti-hepatitis B virus drugs. Virology 169, 213–216 (1989).
    Article CAS Google Scholar
  6. Weller, I.V.D. et al. Acyclovir inhibits hepatitis B virus replication in man. J. antimicrob. Chemother. 11, 223–231 (1983).
    Article CAS Google Scholar
  7. Hoofnagle, J.H. et al. Randomized control trial of adenine arabinoside monophosphate for chronic type B hepatitis. Gastroenterology 86, 150–157 (1984).
    Article CAS Google Scholar
  8. Lok, A.S.F., Wilson, L.A. & Thomas, H.C. Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection. J. antimicrob. Chemother. 14, 93–99 (1984).
    Article CAS Google Scholar
  9. Summers, J. & Mason, W.S. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29, 403–115 (1982).
    Article CAS Google Scholar
  10. Seeger, C., Ganem, D. & Varmus, H.E. Biochemical and genetic evidence for the hepatitis B replication strategy. Science 232, 477–484 (1986).
    Article CAS Google Scholar
  11. Mahley, R.W. & Hussain, M.M. Chylomicron and chylomicron remnant catabolism. Carr. Opin. Lipidol. 2, 170–176 (1991).
    Article CAS Google Scholar
  12. Hoeg, J.M., Demosky, S.J. Jr, Gregg, R.E., Schaefer, E.J. & Brewer, H.B. Jr Distinct hepatic receptors for low density lipoprotein and apolipoprotein E in humans. Science 227, 759–761 (1985).
    Article CAS Google Scholar
  13. Bijsterbosch, M.K. & van Berkel, Th.J.C. Native and modified lipoproteins as drug delivery systems. Adv. Drug Delivery Rev. 5, 231–251 (1990).
    Article CAS Google Scholar
  14. Shaw, J.M. ed Lipoproteins as carriers of pharmaceutical agents (Marcel Dekker, Inc, New York, 1991).
    Google Scholar
  15. Van Dijk, M.C.M. et al. Recognition of chylomicron remnants and β-migrating very-low-density lipoproteins by the remnant receptor of parenchymal liver cells is distinct from the liver α2-macroglobulin-recognition site. Biochem. J. 279, 863–870 (1991).
    Article CAS Google Scholar
  16. Mahley, R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622–630 (1988).
    Article CAS Google Scholar
  17. Windier, E., Chao, Y.S. & Havel, R.J. Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat: opposing effects of homologous apolipoprotein E and individual C apoproteins. J. Boil. Chem. 255, 8303–8307 (1980).
    Google Scholar
  18. Van Berkel, Th.J.C., Kruijt, J.K., Scheek, L.M. & Groot, P.H.E. Effect of apolipoproteins E and C-III on the interaction of chylomicrons with parenchymal and non-parenchymal cells from rat liver. Biochem. J. 216, 71–80 (1983).
    Article CAS Google Scholar
  19. Vogel, T. et al. Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E. Proc. natn. Acad. Sci. U.S.A. 82, 8696–8700 (1985).
    Article CAS Google Scholar
  20. Huettinger, M., Retzek, H., Eder, M. & Goldenberg, H. Characteristics of chylomicron remnant uptake into rat liver. Clin. Biochem. 21, 87–92 (1988).
    Article CAS Google Scholar
  21. Chen, Z., Keech, A. et al. Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer. Brit. med. J. 306, 890–894 (1993).
    Article CAS Google Scholar
  22. Price, P.M., Banerjee, R. & Acs, G. Inhibition of the replication of hepatitis B virus by the carbocyclic analog of 2′-deoxyguanosine. Proc. natn. Acad. Sci. U.S.A. 86, 8543–8544 (1989).
    Google Scholar
  23. Lin, T.S. et al. Synthesis and biological evaluation of 2′,3′-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). J. med. Chem. 37, 798–803 (1994).
    Article CAS Google Scholar
  24. Summers, J., Smolec, J.M. & Snyder, R. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc. natn. Acad. Sci. U.S.A. 75, 4533–4537 (1978).
    Article CAS Google Scholar
  25. Tennant, B.D. & Gerin, J.L. The woodchuck model of hepatitis B virus infection. In: The Liver: Biology and Pathobiology (eds. Arias, I.M. et al.) 1455–1466 (Raven, New York 1994).
    Google Scholar
  26. Périgaud, C., Gosselin, G. & Imbach, J.L. Nucleoside analogues as chemotherapeutic agents; a review. Nucleos. Nucleot. 11, 903–945 (1992).
    Article Google Scholar
  27. Sacks, S.L. et al. Toxicity of vidarabine. JAMA 241, 28–29 (1979).
    Article CAS Google Scholar
  28. Sacks, S.L. et al. Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination. Antimicrob. Agents Chemother. 21, 93–100 (1982).
    Article CAS Google Scholar
  29. Redgrave, T.G. & Maranhao, R.C. Metabolism of protein-free lipid emulsion models of chylomicrons in rats. Biochim. biophys. Acta. 835, 104–112 (1985).
    Article CAS Google Scholar
  30. Bijsterbosch, M.K., Schouten, D. & van Berkel, Th.J.C. Synthesis of the dioleoyl derivative of iododeoxyuridine and its incorporation into reconstituted high density lipoprotein particles. Biochemistry 33, 14073–14080 (1994).
    Article CAS Google Scholar
  31. Bijsterbosch, M.K., Ziere, G.J. & van Berkel, Th.J.C. Lactosylated low density lipoprotein: a potential carrier for the site-specific delivery of drugs to Kupffer cells. Mol. Pharmacol. 36, 484–489 (1989).
    CAS PubMed Google Scholar
  32. Van Berkel, Th.J.C., Dekker, C.J., Kruijt, J.K. & van Eijk, H.G. The interaction in vivo of transferrin and asialotransferrin with liver cells. Biochem. J. 243, 715–722 (1987).
    Article CAS Google Scholar
  33. Blouin, A., Bolender, R.D. & Weibel, E.R. Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma: a stereological study. J. Cell. Biol. 72, 441–455 (1977).
    Article CAS Google Scholar
  34. Nagelkerke, J.F., Barto, K.P. & van Berkel, Th.J.C. In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer and parenchymal cells. J. biol. Chem. 258, 12221–12227 (1983).
    CAS PubMed Google Scholar

Download references